PatentsUSA
Moderna to Pay Up to $2.25B to Settle COVID-19 Vaccine Patent Lawsuit
Biotechnology company Moderna has agreed to pay up to $2.25 billion to settle patent litigation over technology used in its COVID-19 vaccine, resolving a dispute with Arbutus Biopharma and Genevant Sciences. The lawsuits alleged that Moderna’s vaccine relied on patented lipid nanoparticle delivery systems, a technolog…
Wednesday, April 29, 2026